Kairos Ventures
Kairos Ventures invests in groundbreaking startups and research in life sciences, physical sciences, and technology, originating from the top minds of academia and industry. These technologies have the potential to make the world a better place.
Founded 2015 · Venture Capital
Beverly Hills (
United States), Pasadena (United States), New York (United States), Washington D.C. (United States), Austin (United States)
United States), Pasadena (United States), New York (United States), Washington D.C. (United States), Austin (United States)Investment Stages
Seed
Series A
Series B
Markets
Life Sciences
Physical Sciences
Portfolio Companies
1200 Pharma, Actinia, Actuate Therapeutics, Amorphology, Avvio Medical, Axial Therapeutics, Behavioral Signals, Chimera Bioengineering, Clearsense, CytoDel, DEARhealth, Delpor, Foldax, GuRu, Holoclara, KMLabs, LifeSprout, Linnaeus, Mattiq, MemVerge, MidIR, MixComm, NanoClear Technologies, Neuro-Bio, nFugue, NVasc, Pomelo, Provivi, PteroDynamics, Quicksilver Biosciences, Sienza Energy, Specter Aerospace, Transient Plasma Systems (TPS), Vivodyne, Wonder Blades, Xidas
Related VC firms in United States